Literature DB >> 16520485

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

Norberto C Chavez-Tapia, Nahum Mendez-Sanchez, Misael Uribe.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16520485     DOI： 10.7326/0003-4819-144-5-200603070-00021

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Gregory J Gores
Journal:  Clin Lipidol       Date:  2010-02-01

Review 2.  Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.

Authors:  Tim C M A Schreuder; Bart J Verwer; Carin M J van Nieuwkerk; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

3.  Mcl-1 degradation during hepatocyte lipoapoptosis.

Authors:  Howard C Masuoka; Justin Mott; Steven F Bronk; Nathan W Werneburg; Yuko Akazawa; Scott H Kaufmann; Gregory J Gores
Journal:  J Biol Chem       Date:  2009-09-05       Impact factor: 5.157

4.  Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.

Authors:  Yongyuan Zhang; Tao Zhang; Chengqi Zhang; Fang Tang; Nvjuan Zhong; Hongkai Li; Xinhong Song; Haiyan Lin; Yanxun Liu; Fuzhong Xue
Journal:  BMJ Open       Date:  2015-09-22       Impact factor: 2.692

5.  Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.

Authors:  Juan M Decara; Francisco Javier Pavón; Juan Suárez; Miguel Romero-Cuevas; Elena Baixeras; Mariam Vázquez; Patricia Rivera; Ana L Gavito; Bruno Almeida; Jesús Joglar; Rafael de la Torre; Fernando Rodríguez de Fonseca; Antonia Serrano
Journal:  Dis Model Mech       Date:  2015-10-01       Impact factor: 5.758
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.